Lyu, Su Ir
ORCID: 0009-0002-4125-6048, Fretter, Caroline, Hillmer, Axel M.
ORCID: 0000-0002-3381-7266, Grothey, Bastian
ORCID: 0000-0002-0883-6481, Hoppe, Sascha
ORCID: 0000-0001-9246-3747, Simon, Adrian Georg
ORCID: 0000-0002-2709-863X, Zander, Thomas
ORCID: 0000-0002-4266-6818, Knipper, Karl
ORCID: 0009-0008-7133-3538, Schroeder, Wolfgang
ORCID: 0000-0002-8700-069X, Bruns, Christiane J.
ORCID: 0000-0001-6590-8181 and Quaas, Alexander
ORCID: 0000-0002-3537-6011
(2025).
Basal-like subtype of esophageal adenocarcinoma and it’s morphological, molecular and clinical characteristics.
Scientific Reports, 15 (1).
pp. 1-12.
Springer Nature.
ISSN 2045-2322
|
PDF
s41598-025-08721-9.pdf Bereitstellung unter der CC-Lizenz: Creative Commons Attribution. Download (2MB) |
Abstract
[Artikel-Nr.: 24680] Esophageal adenocarcinoma (EAC) and squamous cell carcinoma are the two main tumor types of the esophagus, each with distinct morphological and molecular features. While mixed adeno-squamous carcinomas are recognized, it remains unclear whether a basal-like subtype—known from breast and pancreatic adenocarcinomas—also exists in EAC. This study analyzed tumor samples from 953 patients with operable EAC for expression of the basal cytokeratins CK5 and CK6. Tumors with any squamous differentiation were excluded. A small subset (3.4%) showed a basal-like phenotype, characterized by high CK5 and/or CK6 expression and small-luminal tubular growth. High CK5 expression was associated with significantly worse overall survival, and within the neoadjuvantly treated subgroup, it emerged as an independent negative prognostic marker. Tumors with concurrent high CK5 and CK6 expression also showed reduced survival. Exploratory analyses revealed potential associations between CK6 expression and Claudin18.2 status, and between CK5 expression and Y-chromosome loss. These findings indicate the presence of a distinct basal-like subtype within EAC, linked to poor prognosis and possible molecular differences. CK5, alone or in combination with CK6, may serve as a practical biomarker for identifying this subtype and could support the development of more personalized treatment strategies.
| Item Type: | Article |
| Creators: | Creators Email ORCID ORCID Put Code Fretter, Caroline UNSPECIFIED UNSPECIFIED UNSPECIFIED |
| URN: | urn:nbn:de:hbz:38-809564 |
| Identification Number: | 10.1038/s41598-025-08721-9 |
| Journal or Publication Title: | Scientific Reports |
| Volume: | 15 |
| Number: | 1 |
| Page Range: | pp. 1-12 |
| Number of Pages: | 12 |
| Date: | 9 July 2025 |
| Publisher: | Springer Nature |
| ISSN: | 2045-2322 |
| Language: | English |
| Faculty: | Faculty of Medicine |
| Divisions: | Faculty of Medicine > Chirurgie > Klinik und Poliklinik für Allgemein-, Viszeral-, Thorax- und Transplantationschirurgie Faculty of Medicine > Innere Medizin > Klinik II für Innere Medizin - Nephrologie, Rheumatologie, Diabetologie und Allgemeine Innere Medizin Faculty of Medicine > Pathologie und Neuropathologie > Institut für Pathologie |
| Subjects: | Medical sciences Medicine |
| Uncontrolled Keywords: | Keywords Language Esophageal adenocarcinoma ; Cytokeratin 5 ; Cytokeratin 6 ; Basal-like subtype ; Poor prognosis English |
| ['eprint_fieldname_oa_funders' not defined]: | Publikationsfonds UzK |
| Refereed: | Yes |
| URI: | http://kups.ub.uni-koeln.de/id/eprint/80956 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
![]() |
View Item |
https://orcid.org/0009-0002-4125-6048